Mice producing reduced levels of insulin-like growth factor type 1 display an increase in maximum, but not mean, life span

Journals of Gerontology - Series A Biological Sciences and Medical Sciences

Volumn 69, Issue 4, 2014, Pages 410-419

  Lorenzini, Antonello ^a,b   Salmon, Adam B ^c,d   Lerner, Chad ^b   Torres, Claudio ^b   Ikeno, Yuji ^c,d   Motch, Susan ^e   McCarter, Roger ^e   Sell, Christian ^b  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^d GERIATRIC RESEARCH EDUCATION AND CLINICAL CENTER   (United States)

^e PENNSYLVANIA STATE UNIVERSITY   (United States)

Author keywords

Gluconeogenesis.; IGF 1; Insulin; Metabolism; Obesity

Indexed keywords

INSULIN; SOMATOMEDIN C;

AGING; ANIMAL; ARTICLE; C57BL MOUSE; FEMALE; GENE EXPRESSION REGULATION; GENETICS; GENOTYPE; GLUCONEOGENESIS.; IGF-1; LONGEVITY; METABOLISM; MOUSE; OBESITY; PHYSIOLOGY;

GLUCONEOGENESIS.; IGF-1; INSULIN; METABOLISM; OBESITY;

AGING; ANIMALS; FEMALE; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENOTYPE; INSULIN-LIKE GROWTH FACTOR I; LONGEVITY; MICE; MICE, INBRED C57BL;

EID: 84898976404     PISSN: 10795006     EISSN: 1758535X     Source Type: Journal    
DOI: 10.1093/gerona/glt108     Document Type: Article

References (65)

1. Lin K, Dorman JB, Rodan A, Kenyon C. daf-16: An HNF-3/forkhead family member that can function to double the life-span of Caenorhabditis elegans. Science. 1997;278:1319-1322
2. Tatar M, Kopelman A, Epstein D, Tu MP, Yin CM, Garofalo RS. A mutant Drosophila insulin receptor homolog that extends life-span and impairs neuroendocrine function. Science. 2001;292:107-110
3. Kimura KD, Tissenbaum HA, Liu Y, Ruvkun G. daf-2, an insulin receptor-like gene that regulates longevity and diapause in Caenorhabditis elegans. Science. 1997;277:942-946
4. Dorman JB, Albinder B, Shroyer T, Kenyon C. The age-1 and daf-2 genes function in a common pathway to control the lifespan of Caenorhabditis elegans. Genetics. 1995;141:1399-1406
5. Lee RY, Hench J, Ruvkun G. Regulation of C. elegans DAF-16 and its human ortholog FKHRL1 by the daf-2 insulin-like signaling pathway. Curr Biol. 2001;11:1950-1957
6. Brown-Borg HM, Borg KE, Meliska CJ, Bartke A. Dwarf mice and the ageing process. Nature. 1996;384:33
7. Flurkey K, Papaconstantinou J, Harrison DE. The Snell dwarf mutation Pit1(dw) can increase life span in mice. Mech Ageing Dev. 2002;123:121-130
8. Flurkey K, Papaconstantinou J, Miller RA, Harrison DE. Lifespan extension and delayed immune and collagen aging in mutant mice with defects in growth hormone production. Proc Natl Acad Sci U S A. 2001;98:6736-6741
9. Coschigano KT, Clemmons D, Bellush LL, Kopchick JJ. Assessment of growth parameters and life span of GHR/BP gene-disrupted mice. Endocrinology. 2000;141:2608-2613
10. Godfrey P, Rahal JO, Beamer WG, Copeland NG, Jenkins NA, Mayo KE. GHRH receptor of little mice contains a missense mutation in the extracellular domain that disrupts receptor function. Nat Genet. 1993;4:227-232
11. Zhou Y, Xu BC, Maheshwari HG, et al. A mammalian model for Laron syndrome produced by targeted disruption of the mouse growth hormone receptor/binding protein gene (the Laron mouse). Proc Natl Acad Sci U S A. 1997;94:13215-13220
12. Liu JP, Baker J, Perkins AS, Robertson EJ, Efstratiadis A. Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (Igf1r). Cell. 1993;75:59-72
13. Baker J, Liu JP, Robertson EJ, Efstratiadis A. Role of insulin-like growth factors in embryonic and postnatal growth. Cell. 1993;75:73-82
14. Powell-Braxton L, Hollingshead P, Giltinan D, Pitts-Meek S, Stewart T. Inactivation of the IGF-I gene in mice results in perinatal lethality. Ann N Y Acad Sci. 1993;692:300-301
15. Powell-Braxton L, Hollingshead P, Warburton C, et al. IGF-I is required for normal embryonic growth in mice. Genes Dev. 1993;7(12B):2609-2617
16. Baker J, Liu JP, Robertson EJ, Efstratiadis A. Role of insulin-like growth factors in embryonic and postnatal growth. Cell. 1993;75:73-82
17. Liu JL, LeRoith D. Insulin-like growth factor I is essential for postnatal growth in response to growth hormone. Endocrinology. 1999;140:5178-5184
18. Holzenberger M, Dupont J, Ducos B, et al. IGF-1 receptor regulates lifespan and resistance to oxidative stress in mice. Nature. 2003;421:182-187
19. Bokov AF, Garg N, Ikeno Y, et al. Does reduced IGF-1R signaling in Igf1r+/- mice alter aging? PLoS One. 2011;6:e26891
20. Lembo G, Rockman HA, Hunter JJ, et al. Elevated blood pressure and enhanced myocardial contractility in mice with severe IGF-1 deficiency. J Clin Invest. 1996;98:2648-2655
21. Ikeno Y, Hubbard GB, Lee S, et al. Reduced incidence and delayed occurrence of fatal neoplastic diseases in growth hormone receptor/ binding protein knockout mice. J Gerontol A Biol Sci Med Sci. 2009;64:522-529
22. Hammers DW, Matheny RW Jr, Sell C, et al. Impairment of IGF-I expression and anabolic signaling following ischemia/reperfusion in skeletal muscle of old mice. Exp Gerontol. 2011;46:265-272
23. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976;72:248-254
24. Birnboim HC, Wilkinson D, Sandhu JK, McLean JR, Ross W. Mutatect: A mouse tumour model for detecting radiation-induced mutations in vivo. Mutat Res. 1999;430:275-280
25. Arking R. The Biology of Aging: Observations and Principles. Sunderland, MA: Sinauer Associates; 1998
26. D'Ercole AJ, Stiles AD, Underwood LE. Tissue concentrations of somatomedin C: Further evidence for multiple sites of synthesis and paracrine or autocrine mechanisms of action. Proc Natl Acad Sci U S A. 1984;81:935-939
27. Hammers DW, Matheny RW Jr, Sell C, et al. Impairment of IGF-I expression and anabolic signaling following ischemia/reperfusion in skeletal muscle of old mice. Exp Gerontol. 2011;46:265-272
28. Crowe E, Sell C, Thomas JD, Johannes GJ, Torres C. Activation of proteasome by insulin-like growth factor-I may enhance clearance of oxidized proteins in the brain. Mech Ageing Dev. 2009;130:793-800
29. Lupu F, Terwilliger JD, Lee K, Segre GV, Efstratiadis A. Roles of growth hormone and insulin-like growth factor 1 in mouse postnatal growth. Dev Biol. 2001;229:141-162
30. Kadakia R, Arraztoa JA, Bondy C, Zhou J. Granulosa cell proliferation is impaired in the Igf1 null ovary. Growth Horm IGF Res. 2001;11:220-224
31. Zhou J, Chin E, Bondy C. Cellular pattern of insulin-like growth factor- I (IGF-I) and IGF-I receptor gene expression in the developing and mature ovarian follicle. Endocrinology. 1991;129:3281-3288
32. Zhou J, Bondy C. Anatomy of the human ovarian insulin-like growth factor system. Biol Reprod. 1993;48:467-482
33. Grigorescu F, Baccara MT, Rouard M, Renard E. Insulin and IGF-1 signaling in oocyte maturation. Horm Res. 1994;42:55-61
34. Wang J, Zhou J, Cheng CM, Kopchick JJ, Bondy CA. Evidence supporting dual, IGF-I-independent and IGF-I-dependent, roles for GH in promoting longitudinal bone growth. J Endocrinol. 2004;180:247-255
35. Wang J, Zhou J, Bondy CA. Igf1 promotes longitudinal bone growth by insulin-like actions augmenting chondrocyte hypertrophy. FASEB J. 1999;13:1985-1990
36. Bikle D, Majumdar S, Laib A, et al. The skeletal structure of insulin- like growth factor I-deficient mice. J Bone Miner Res. 2001;16: 2320-2329
37. Sell C, Dumenil G, Deveaud C, et al. Effect of a null mutation of the insulin-like growth factor I receptor gene on growth and transformation of mouse embryo fibroblasts. Mol Cell Biol. 1994;14:3604-3612
38. Resnicoff M, Coppola D, Sell C, Rubin R, Ferrone S, Baserga R. Growth inhibition of human melanoma cells in nude mice by antisense strategies to the type 1 insulin-like growth factor receptor. Cancer Res. 1994;54:4848-4850
39. Takahara K, Tearle H, Ghaffari M, Gleave ME, Pollak M, Cox ME. Human prostate cancer xenografts in lit/lit mice exhibit reduced growth and androgen-independent progression. Prostate. 2011;71:525-537
40. Deitel K, Dantzer D, Ferguson P, et al. Reduced growth of human sarcoma xenografts in hosts homozygous for the lit mutation. J Surg Oncol. 2002;81:75-79
41. Yang XF, Beamer WG, Huynh H, Pollak M. Reduced growth of human breast cancer xenografts in hosts homozygous for the lit mutation. Cancer Res. 1996;56:1509-1511
42. Wu Y, Cui K, Miyoshi K, et al. Reduced circulating insulin-like growth factor I levels delay the onset of chemically and genetically induced mammary tumors. Cancer Res. 2003;63:4384-4388
43. Dunn SE, Kari FW, French J, et al. Dietary restriction reduces insulin- like growth factor I levels, which modulates apoptosis, cell proliferation, and tumor progression in p53-deficient mice. Cancer Res. 1997;57:4667-4672
44. Masoro EJ. Caloric restriction-induced life extension of rats and mice: A critique of proposed mechanisms. Biochim Biophys Acta. 2009;1790:1040-1048
45. Sebert S, Sharkey D, Budge H, Symonds ME. The early programming of metabolic health: Is epigenetic setting the missing link? Am J Clin Nutr. 2011;94(6 Suppl):1953S-1958S
46. Berryman DE, Lubbers ER, Magon V, List EO, Kopchick JJ. A dwarf mouse model with decreased GH/IGF-1 activity that does not experience life-span extension: Potential impact of increased adiposity, leptin, and insulin with advancing age. J Gerontol A Biol Sci Med Sci. 2013. [Epub ahead of print]. PMID: 23695394
47. Kawauchi H, Sower SA. The dawn and evolution of hormones in the adenohypophysis. Gen Comp Endocrinol. 2006;148:3-14
48. Forsyth IA, Wallis M. Growth hormone and prolactin-molecular and functional evolution. J Mammary Gland Biol Neoplasia. 2002;7:291-312
49. Maniou Z, Wallis OC, Wallis M. Episodic molecular evolution of pituitary growth hormone in Cetartiodactyla. J Mol Evol. 2004;58:743-753
50. Wallis OC, Wallis M. Molecular evolution of growth hormone (GH) in Cetartiodactyla: Cloning and characterization of the gene encoding GH from a primitive ruminant, the chevrotain (Tragulus javanicus). Gen Comp Endocrinol. 2001;123:62-72
51. Wallis OC, Wallis M. Evolution of growth hormone in primates: The GH gene clusters of the New World monkeys marmoset (Callithrix jacchus) and white-fronted capuchin (Cebus albifrons). J Mol Evol. 2006;63:591-601
52. Fukamachi S, Meyer A. Evolution of receptors for growth hormone and somatolactin in fish and land vertebrates: Lessons from the lungfish and sturgeon orthologues. J Mol Evol. 2007;65:359-372
53. Wallis M. Function switching as a basis for bursts of rapid change during the evolution of pituitary growth hormone. J Mol Evol. 1997;44:348-350
54. Sparkman AM, Schwartz TS, Madden JA, et al. Rates of molecular evolution vary in vertebrates for insulin-like growth factor-1 (IGF- 1), a pleiotropic locus that regulates life history traits. Gen Comp Endocrinol. 2012;178:164-173
55. Romero CJ, Pine-Twaddell E, Sima DI, et al. Insulin-like growth factor 1 mediates negative feedback to somatotroph GH expression via POU1F1/CREB binding protein interactions. Mol Cell Biol. 2012;32:4258-4269
56. Wolf E, Kahnt E, Ehrlein J, Hermanns W, Brem G, Wanke R. Effects of long-Term elevated serum levels of growth hormone on life expectancy of mice: Lessons from transgenic animal models. Mech Ageing Dev. 1993;68:71-87
57. Wu S, Levenson A, Kharitonenkov A, De Luca F. Fibroblast growth factor 21 (FGF21) inhibits chondrocyte function and growth hormone action directly at the growth plate. J Biol Chem. 2012;287: 26060-26067
58. Zhang Y, Xie Y, Berglund ED, et al. The starvation hormone, fibroblast growth factor-21, extends lifespan in mice. Elife. 2012;1:e00065
59. Fernandez AM, Torres-Alemán I. The many faces of insulin-like peptide signalling in the brain. Nat Rev Neurosci. 2012;13:225-239
60. Deak F, Sonntag WE. Aging, synaptic dysfunction, and insulin-like growth factor (IGF)-1. J Gerontol A Biol Sci Med Sci. 2012;67:611-625
61. Li Q, Ren J. Influence of cardiac-specific overexpression of insulinlike growth factor 1 on lifespan and aging-Associated changes in cardiac intracellular Ca2+ homeostasis, protein damage and apoptotic protein expression. Aging Cell. 2007;6:799-806
62. Higashi Y, Sukhanov S, Anwar A, Shai SY, Delafontaine P. Aging, atherosclerosis, and IGF-1. J Gerontol A Biol Sci Med Sci. 2012;67:626-639
63. Panici JA, Harper JM, Miller RA, Bartke A, Spong A, Masternak MM. Early life growth hormone treatment shortens longevity and decreases cellular stress resistance in long-lived mutant mice. FASEB J. 2010;24:5073-5079
64. Sonntag WE, Carter CS, Ikeno Y, et al. Adult-onset growth hormone and insulin-like growth factor I deficiency reduces neoplastic disease, modifies age-related pathology, and increases life span. Endocrinology. 2005;146:2920-2932
65. Sonntag WE, Csiszar A, deCabo R, Ferrucci L, Ungvari Z. Diverse roles of growth hormone and insulin-like growth factor-1 in mammalian aging: Progress and controversies. J Gerontol A Biol Sci Med Sci. 2012;67:587-598.